4//SEC Filing
Hasleton Mark Daniel 4
Accession 0001213900-19-003338
CIK 0001176309other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:58 PM ET
Size
5.5 KB
Accession
0001213900-19-003338
Insider Transaction Report
Form 4
Hasleton Mark Daniel
VP Business Development
Transactions
- Award
Stock Option (right to buy)
2019-02-26+22,500→ 22,500 totalExercise: $3.16Exp: 2029-02-26→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The Stock Option will vest in 4 equal installments of 5,625 on each of December 31, 2019, December 31, 2020, December 31, 2021 and December 31, 2022.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001759581
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:58 PM ET
- Size
- 5.5 KB